First‐line epidermal growth factor receptor (
            EGFR
            )–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with
            EGFR
            ‐mutated lung adenocarcinoma

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

First Line ◽

Brain Radiotherapy ◽

Epidermal Growth ◽

Egfr Mutated

Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)

Journal of Chemotherapy ◽

10.1179/1973947815y.0000000027 ◽

2016 ◽

Vol 28 (1) ◽

pp. 50-58 ◽

Cited By ~ 4

Author(s):

Yen-Han Tseng ◽

Hsiu-Ying Hung ◽

Yi-Chen Sung ◽

Yen-Chiang Tseng ◽

Yu-Chin Lee ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

First Line ◽

Epidermal Growth ◽

Egfr Mutated

Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases

Current Medical Science ◽

10.1007/s11596-018-1984-0 ◽

2018 ◽

Vol 38 (6) ◽

pp. 1062-1068 ◽

Cited By ~ 4

Author(s):

Shao-bo Ke ◽

Hu Qiu ◽

Jia-mei Chen ◽

Wei Shi ◽

Yong-shun Chen

Keyword(s):

Receptor Tyrosine Kinase ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

First Line ◽

Brain Radiotherapy ◽

Epidermal Growth ◽

Egfr Tki

Epidermal Growth Factor Receptor (EGFR)‐Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR‐Mutated Elderly Pulmonary Adenocarcinoma Patients

The Oncologist ◽

10.1634/theoncologist.2014-0352 ◽

2015 ◽

Vol 20 (7) ◽

pp. 758-766 ◽

Cited By ~ 2

Author(s):

Yen‐Han Tseng ◽

Yen‐Chiang Tseng ◽

Yi‐hsuan Lin ◽

Yu‐Chin Lee ◽

Reury‐Perng Perng ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Salvage Chemotherapy ◽

Epidermal Growth ◽

Egfr Mutated ◽

Inhibitor Treatment

Efficacy of platinum-based combination chemotherapy in advanced lung adenocarcinoma harboring sensitive epidermal growth factor receptor (EGFR) mutations with acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2016.07.005 ◽

2016 ◽

Vol 9 ◽

pp. 48-55 ◽

Cited By ~ 3

Author(s):

Ping-Chih Hsu ◽

Chien-Ying Liu ◽

Shih-Hong Li ◽

Shih-How Huang ◽

Chih-Liang Wang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

First Line ◽

Real-world (RW) treatment patterns and outcomes for second-line (2L) therapy and beyond in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC receiving a first-line (1L) first- or second-generation (1G/2G) EGFR tyrosine kinase inhibitor (TKI)

Annals of Oncology ◽

10.1093/annonc/mdz260.044 ◽

2019 ◽

Vol 30 ◽

pp. v624-v625 ◽

Cited By ~ 1

Author(s):

R. Shah ◽

N. Girard ◽

S.P. Nagar ◽

F. Griesinger ◽

J. Roeper ◽

...

Keyword(s):

Growth Factor ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Second Line ◽

First Line ◽

Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation

Journal of Thoracic Disease ◽

10.21037/jtd.2016.05.70 ◽

2016 ◽

Vol 8 (7) ◽

pp. 1504-1512 ◽

Cited By ~ 2

Author(s):

Jin-Rui Li ◽

Ye Zhang ◽

Jia-Lian Zheng

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Whole Brain ◽

Brain Radiotherapy ◽

A review of whole brain radiotherapy outcomes in a high epidermal growth factor receptor mutation rate population: Does QUARTZ apply in Asia?

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13223 ◽

2019 ◽

Vol 15 (6) ◽

pp. 353-357 ◽

Cited By ~ 1

Author(s):

Ivy Weishan Ng ◽

Jeremy Chee Seong Tey ◽

David Wei Tsau Chia ◽

Choon Meng Yee ◽

Timothy Song Tao Cheo

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Mutation Rate ◽

Growth Factor Receptor ◽

Whole Brain ◽

Brain Radiotherapy ◽

The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma

Surgery Today ◽

10.1007/s00595-011-4514-2 ◽

2011 ◽

Vol 41 (6) ◽

pp. 818-823 ◽

Cited By ~ 3

Author(s):

Daigo Kawano ◽

Tokujiro Yano ◽

Fumihiro Shoji ◽

Kensaku Ito ◽

Yosuke Morodomi ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Signal Activation ◽

Inhibitor Treatment

The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Cancer Research and Treatment ◽

10.4143/crt.2017.512 ◽

2018 ◽

Vol 50 (4) ◽

pp. 1294-1303 ◽

Cited By ~ 14

Author(s):

Yen-Hsiang Huang ◽

Kuo-Hsuan Hsu ◽

Jeng-Sen Tseng ◽

Kun-Chieh Chen ◽

Chia-Hung Hsu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Clinical Characteristics ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

First Line ◽

T790m Mutation ◽

Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2016.190 ◽

2017 ◽

Vol 32 (3) ◽

pp. 422-428 ◽

Cited By ~ 1

Author(s):

Yong Won Choi ◽

Jin-Hyuk Choi

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽